The WWOX gene modulates high-density lipoprotein and lipid metabolism

Circulation: Cardiovascular Genetics

Volumn 7, Issue 4, 2014, Pages 491-504

  Iatan, Iulia ^a   Choi, Hong Y ^a   Ruel, Isabelle ^a   Linga Reddy, M V Prasad ^b   Kil, Hyunsuk ^c   Lee, Jaeho ^c   Abu Odeh, Mohammad ^d   Salah, Zaidoun ^d,e   Abu Remaileh, Muhannad ^d   Weissglas Volkov, Daphna ^b   Nikkola, Elina ^b   Civelek, Mete ^f   Awan, Zuhier ^a   Croce, Carlo M ^f   Aqeilan, Rami I ^d,f   Pajukanta, Päivi ^b   Aldaz, C Marcelo ^c   Genest, Jacques ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d HEBREW UNIVERSITY   (Israel)

^e AL QUDS UNIVERSITY   (Palestine)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

ABCA1; Apolopoprotein A I; Cardiovascular diseases; Genetics; HDL Cholesterol; Lipids; WWOX protein

Indexed keywords

ABC TRANSPORTER A1; ANGIOPOIETIN LIKE 4; APOLIPOPROTEIN A1; FAS ANTIGEN; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANGIOPOIETIN; ANGPTL4 PROTEIN, MOUSE; FAS PROTEIN, MOUSE; LIPG PROTEIN, MOUSE; OXIDOREDUCTASE; TRIACYLGLYCEROL LIPASE; TUMOR SUPPRESSOR PROTEIN; WWOX PROTEIN, HUMAN; WWOX PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOBLOTTING; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; LIPID HOMEOSTASIS; LIPOPROTEIN METABOLISM; LIVER; MALE; MICROARRAY ANALYSIS; MOUSE; NEXT GENERATION SEQUENCING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SERUM; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WWOX GENE; ADOLESCENT; ADULT; AGED; ALLELE; ANIMAL; BLOOD; C57BL MOUSE; CHROMOSOME 16; DEFICIENCY; DNA SEQUENCE; GENETICS; HAPLOTYPE; HIGH THROUGHPUT SEQUENCING; KNOCKOUT MOUSE; LIPID METABOLISM; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

MUS;

ADOLESCENT; ADULT; AGED; ALLELES; ANGIOPOIETINS; ANIMALS; ANTIGENS, CD95; APOLIPOPROTEIN A-I; ATP BINDING CASSETTE TRANSPORTER 1; CHOLESTEROL, HDL; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; HAPLOTYPES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIPASE; LIPID METABOLISM; LIPOPROTEINS, HDL; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; OXIDOREDUCTASES; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TRIGLYCERIDES; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84925298996     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.113.000248     Document Type: Article

References (53)

1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952
2. Heller DA, de Faire U, Pedersen NL, Dahlén G, McClearn GE. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med. 1993;328:1150-1156
3. Lee JC, Weissglas-Volkov D, Kyttälä M, Dastani Z, Cantor RM, Sobel EM, et al. WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels. Am J Hum Genet. 2008;83:180-192
4. Leduc MS, Lyons M, Darvishi K, Walsh K, Sheehan S, Amend S, et al. The mouse QTL map helps interpret human genome-wide association studies for HDL cholesterol. J Lipid Res. 2011;52:1139-1149
5. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161-169
6. Sáez ME, González-Pérez A, Martínez-Larrad MT, Gayán J, Real LM, Serrano-Ríos M, et al. WWOX gene is associated with HDL cholesterol and triglyceride levels. BMC Med Genet. 2010;11:148
7. Vasan RS, Glazer NL, Felix JF, Lieb W, Wild PS, Felix SB, et al. Genetic variants associated with cardiac structure and function: A meta-Analysis and replication of genome-wide association data. JAMA. 2009;302:168-178
8. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 2000;60:2140-2145
9. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, et al. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet. 2000;9:1651-1663
10. Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y, et al. Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci U S A. 2007;104:3949-3954
11. Ludes-Meyers JH, Kil H, Parker-Thornburg J, Kusewitt DF, Bedford MT, Aldaz CM. Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PLoS One. 2009;4:e7775
12. Del Mare S, Kurek KC, Stein GS, Lian JB, Aqeilan RI. Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma. Am J Cancer Res. 2011;1:585-594
13. Aqeilan RI, Hassan MQ, de Bruin A, Hagan JP, Volinia S, Palumbo T, et al. The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem. 2008;283:21629-21639
14. Del Mare S, Salah Z, Aqeilan RI. WWOX: its genomics, partners, and functions. J Cell Biochem. 2009;108:737-745
15. Sudol M. Structure and function of the WW domain. Prog Biophys Mol Biol. 1996;65:113-132
16. Salah Z, Alian A, Aqeilan RI. WW domain-containing proteins: retrospectives and the future. Front Biosci. 2012;17:331-348
17. Aqeilan RI, Pekarsky Y, Herrero JJ, Palamarchuk A, Letofsky J, Druck T, et al. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci U S A. 2004;101:4401-4406
18. Ludes-Meyers JH, Kil H, Bednarek AK, Drake J, Bedford MT, Aldaz CM. WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins. Oncogene. 2004;23:5049-5055
19. Salah Z, Aqeilan R, Huebner K. WWOX gene and gene product: tumor suppression through specific protein interactions. Future Oncol. 2010;6:249-259
20. Aqeilan RI, Hagan JP, de Bruin A, Rawahneh M, Salah Z, Gaudio E, et al. Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology. 2009;150:1530-1535
21. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem. 1999;274:305-315
22. Krimbou L, Hajj Hassan H, Blain S, Rashid S, Denis M, Marcil M, et al. Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines. J Lipid Res. 2005;46:1668-1677
23. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80
24. Smyth GK, Michaud J, Scott HS. Use of within-Array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005;21:2067-2075
25. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3
26. Langfelder P, Horvath S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559
27. Plaisier CL, Horvath S, Huertas-Vazquez A, Cruz-Bautista I, Herrera MF, Tusie-Luna T, et al. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia. PLoS Genet. 2009;5:e1000642
28. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics. 2008;24:719-720
29. Plaisier CL, Horvath S, Huertas-Vazquez A, Cruz-Bautista I, Herrera MF, Tusie-Luna T, et al. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia. PLoS Genet. 2009;5:e1000642
30. Sherman BT, Huang da W, Tan Q, Guo Y, Bour S, Liu D, et al. DAVID Knowledgebase: A gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics. 2007;8:426
31. Dastani Z, Quiogue L, Plaisier C, Engert JC, Marcil M, Genest J, et al. Evidence for a gene influencing high-density lipoprotein cholesterol on chromosome 4q31.21. Arterioscler Thromb Vasc Biol. 2006;26:392-397
32. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999;22:336-345
33. Dastani Z, Pajukanta P, Marcil M, Rudzicz N, Ruel I, Bailey SD, et al. Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjects. Eur J Hum Genet. 2010;18:342-347
34. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25
35. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078-2079
36. Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467:52-58
37. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-1073
38. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164
39. Lange K, Sinsheimer JS, Sobel E. Association testing with Mendel. Genet Epidemiol. 2005;29:36-50
40. Dastani Z, Pajukanta P, Marcil M, Rudzicz N, Ruel I, Bailey SD, et al. Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjects. Eur J Hum Genet. 2010;18:342-347
41. Lee JC, Weissglas-Volkov D, Kyttälä M, Dastani Z, Cantor RM, Sobel EM, et al. WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels. Am J Hum Genet. 2008;83:180-192
42. Tölle M, Huang T, Schuchardt M, Jankowski V, Prüfer N, Jankowski J, et al. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. Cardiovasc Res. 2012;94:154-162
43. Lichtenstein L, Kersten S. Modulation of plasma TG lipolysis by angiopoietin-like proteins and GPIHBP1. Biochim Biophys Acta. 2010;1801:415-420
44. Lichtenstein L, Berbée JF, van Dijk SJ, van Dijk KW, Bensadoun A, Kema IP, et al. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL-And HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol. 2007;27:2420-2427
45. Mahaney MC, Almasy L, Rainwater DL, VandeBerg JL, Cole SA, Hixson JE, et al. A quantitative trait locus on chromosome 16q influences variation in plasma HDL-C levels in Mexican Americans. Arterioscler Thromb Vasc Biol. 2003;23:339-345
46. Shearman AM, Ordovas JM, Cupples LA, Schaefer EJ, Harmon MD, Shao Y, et al. Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: A genome-wide scan in the Framingham study. Hum Mol Genet. 2000;9:1315-1320
47. Soro A, Pajukanta P, Lilja HE, Ylitalo K, Hiekkalinna T, Perola M, et al. Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families. Am J Hum Genet. 2002;70:1333-1340
48. Iatan I, Bailey D, Ruel I, Hafiane A, Campbell S, Krimbou L, et al. Membrane microdomains modulate oligomeric ABCA1 function: impact on apoAI-mediated lipid removal and phosphatidylcholine biosynthesis. J Lipid Res. 2011;52:2043-2055
49. Aqeilan RI, Donati V, Palamarchuk A, Trapasso F, Kaou M, Pekarsky Y, et al. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res. 2005;65:6764-6772
50. Aqeilan RI, Croce CM. WWOX in biological control and tumorigenesis. J Cell Physiol. 2007;212:307-310
51. Marcil M, Bissonnette R, Vincent J, Krimbou L, Genest J. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency. Circulation. 2003;107:1366-1371
52. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009;41:56-65
53. Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest. 2005;115:1333-1342.